According to the results of previous studies, NEDD4L plays an anti-inflammatory and anti-fibrotic role in IPF by targeting ubiquitination and degradation of TGFBR2 (Li et al. 2023). The gene discussed is TGFBR2; the disease is idiopathic pulmonary fibrosis.